Garvey, W.T., et al., Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
An analysis of 26 studies (total 3020 patients) including 5 studies with psychiatric symptoms assessed as primary outcomes (for example, substance use disorders), and 21 studies with secondary outcomes, as well as an additional 10 registered clinical studies, was performed
The large surface area of the pulmonary bed enables rapid absorption of GLP-1, which can mimic postprandial GLP-1 secretion
Prescribing rules, BMI thresholds, contraindications, and what insurance covers
Lawsuits Against GLP-1 Online Distributors With the rise of telehealth and online pharmacies, many patients obtained GLP-1 weight loss medications through online distributors that failed to provide adequate warnings or proper medical oversight